Pulmonary embolism (PE) is the most preventable cause of inhospital death. Although safe and effective, thrombolytic therapy is relatively contraindicated within 10 days of major surgery due to the risk of bleeding. Our patient developed submassive PE, within 48 h of surgery and had catheter-directed thrombolysis with Streptokinase (STK) injection successfully, without any bleeding complications. This case demonstrates that thrombolysis may be safely and effectively done in postoperative patients. In such scenarios, where the therapy is relatively contraindicated, the decision whether to thrombolyse or not, must be multidisciplinary, giving utmost importance to the patient's best interest and to ensure that no single individual is denied potentially life-saving therapy.
INTRODUCTION
Pulmonary embolism (PE) and deep vein thrombosis (DVT) constitute one of the big three cardiovascular killers along with myocardial infarction and stroke. The case fatality for PE, approximately 15%, exceeds the mortality rate for acute myocardial infarction. PE has been known as a great masquerader because it mimics other illnesses such as pneumonia and congestive heart failure. Once the diagnosis of acute PE is established, rapid and precise risk stratification is of paramount importance.
Normotensive patients with acute PE and evidence of right ventricular (RV) dysfunction are classified as having submassive PE. [1] Although advanced therapy with fibrinolysis is considered a life-saving intervention in massive PE, it remains controversial in patients with submassive PE. [2] 
CASE REPORT
We report a case of 70-year-old lady, with high body mass index (BMI), history of hypothyroidism on regular treatment. She underwent laparoscopic cholecystectomy under general anesthesia. After 2 days, while in the ward, she developed sudden onset dyspnea, tachypnea, and tachycardia. The patient was hemodynamically stable and O 2 saturation in room air was 85%. Investigation revealed elevated cardiac troponin 480 ng/mL [normal responders (NR) 0-60 ng/mL], D dimer: 500 ng/mL (NR <500 ng/mL), N-terminal of the prohormone brain natriuretic peptide (pro NT BNP): 15,600 pg/mL (NR <500 pg/mL). A 12-lead electrocardiogram (ECG) revealed: S1 Q3 T3, T inversion in precordial chest leads.
Bedside screening of two-dimensional (2D) transthoracic echocardiogram showed enlarged right atrium (RA), right ventricle (RV), hypokinesia of RV free wall, interventricular septal flattening, and paradoxical motion toward the left ventricle Follow-up CTPA on the 10th day showed only residual partial thrombus in the segmental arteries,[ Figure 3 ] with no evidence of RV strain. The patient was discharged with advice to continue with oral anticoagulants and have regular outpatient follow-up.
DISCUSSION
Acute PE represents a spectrum of clinical syndromes with a variety of prognostic implications. Patients with acute PE who have normal systemic arterial pressure and preserved RV function have an excellent prognosis with therapeutic anticoagulation alone. In contrast, patients with massive PE present with syncope, systemic arterial hypotension, cardiogenic shock, or cardiac arrest and have an increased risk of adverse outcomes, including death. [3] Our patient, even though hemodynamically stable, showed evidence of RV dysfunction as cardiac biomarkers; both cardiac troponin I and pro NT BNP were elevated. ECG showed T inversion in precordial chest leads and combination of an S wave in lead I, Q wave in lead III, and T-wave inversion in lead III (S1Q3T3) signify RV strain. Transthoracic echocardiogram showed characteristic echocardiographic findings seen in patients with submassive PE.
Such patients may initially appear clinically stable. However, even if they are normotensive initially, despite adequate heparin anticoagulation, patients with RV hypokinesis are at a high risk of recurrent PE and clinical deterioration; [4] [5] [6] these patients should be treated more aggressively with thrombolytic therapy. As per the guidelines of the American College of Chest Physicians, the use of thrombolytic therapy is recommended for patients with evidence of hemodynamic compromise, unless there is major contraindication owing to bleeding risk (Grade1 B) and in selected high risk patients without hypotension who are judged to have a low risk of bleeding,(Grade 2 B). [7] Our patient was first anticoagulated with intravenous unfractionated heparin. Intravenous unfractionated heparin offers the advantage of immediate discontinuation and rapid reversal in the event of bleeding complications. Once embolism was confirmed, catheter-directed intrapulmonary thrombolysis with STK was started. Considering the early postoperative state, STK was given into the pulmonary artery at a lower dose, hoping to reduce bleeding complications. Recurrent showers of embolism were suspected, as the patient continued to be tachypneic and had a drop in O 2 saturation; hence, the dose of STK was increased and infusion continued for a further 24 h.
Thrombolysis in high risk PE patients remains controversial. [8] The fear is that, the risk of bleeding complications, especially intracranial hemorrhage, outweighs any potential benefit. Women may not gain as much benefit from PE thrombolysis as men do.
However, once it occurs, it is difficult to diagnose, expensive to treat, and potentially lethal despite therapy. Therefore, venous thromboembolism (VTE) prevention is of paramount importance. Low-fixed-dose anticoagulant prophylaxis is effective. [9] CONCLUSION To conclude, acute PE is the third most common cause of death among hospitalized patients; [10] acute PE should be suspected in postoperative patients who develop a sudden onset of shortness of breath. Catheter-directed thrombolysis with low-dose STK injection may be considered in postoperative submassive PE, on who continued intravenous heparin has not produced the desired result. In addition, we would like to emphasize, that the treatment strategy for each patient should be individualized, keeping in view the risks and benefits of each treatment option available. If not diagnosed and treated promptly and aggressively, PE could be fatal.
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